# Krensavage Asset Management, LLC 13F Q2 2026: $263 million

Krensavage Asset Management, LLC reported $263 million in 13F securities across 18 positions for the quarter ended June 30, 2026, in a holdings report filed August 14, 2026. Its largest holding was Enanta Pharmaceuticals Inc at $41.8 million, 15.9% of the reported value. Since Q1 2026 it opened 0 new positions and exited 2.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $263,223,000
- Positions: 18
- Filed: August 14, 2026
- Report type: 13F holdings report
- CIK: 1609251
- Form 13F file number: 028-16807
- Business address: 610 Fifth Avenue Suite 301, New York, NY 10020
- Values: This filing states its values in thousands of dollars; they are multiplied by 1,000 here
- SEC filing: [0001609251-26-000005](https://www.sec.gov/Archives/edgar/data/1609251/000160925126000005/0001609251-26-000005-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/krensavage-asset-management-llc-168976)

## Top 18 holdings by value

The largest of 18 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Enanta Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/enanta-pharmaceuticals-inc-29251m106) | COM | 2,866,138 | $41.8 million | No change |
| [Jazz Pharmaceuticals PLC](https://specstream.ai/data/institutional-holders/jazz-pharmaceuticals-plc-g50871105) | SHS USD | 167,816 | $40.4 million | No change |
| [United Therapeutics Corp Del](https://specstream.ai/data/institutional-holders/united-therapeutics-corp-del-91307c102) | COM | 69,282 | $37.5 million | -15,000 |
| [Biomarin Pharmaceutical Inc](https://specstream.ai/data/institutional-holders/biomarin-pharmaceutical-inc-09061g101) | COM | 524,786 | $30 million | No change |
| [Exelixis Inc](https://specstream.ai/data/institutional-holders/exelixis-inc-30161q104) | COM | 370,693 | $20.2 million | -45,000 |
| [Abbott Laboratories](https://specstream.ai/data/institutional-holders/abbott-laboratories-002824100) | COM | 200,000 | $18.1 million | +195,000 |
| [Sanofi SA](https://specstream.ai/data/institutional-holders/sanofi-sa-80105n105) | SPONSORED ADR | 323,946 | $13.8 million | No change |
| [Supernus Pharmaceuticals](https://specstream.ai/data/institutional-holders/supernus-pharmaceuticals-868459108) | COM | 280,681 | $13.1 million | No change |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 390,879 | $13.1 million | No change |
| [Vanda Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/vanda-pharmaceuticals-inc-921659108) | COM | 1,180,388 | $7.2 million | No change |
| [Biontech Se](https://specstream.ai/data/institutional-holders/biontech-se-09075v102) | SPONSORED ADS | 59,523 | $5.5 million | No change |
| [GSK PLC](https://specstream.ai/data/institutional-holders/gsk-plc-37733w204) | SPONSORED ADR | 96,729 | $5.1 million | No change |
| [Biogen Inc](https://specstream.ai/data/institutional-holders/biogen-inc-09062x103) | COM | 20,000 | $4.3 million | No change |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/institutional-holders/regeneron-pharmaceuticals-75886f107) | COM | 6,000 | $3.7 million | +2,000 |
| [Embecta Corp](https://specstream.ai/data/institutional-holders/embecta-corp-29082k105) | COMMON STOCK | 1,135,340 | $3.7 million | +400,000 |
| [Ardelyx Inc](https://specstream.ai/data/institutional-holders/ardelyx-inc-039697107) | COM | 534,523 | $2.7 million | +34,523 |
| [Inmode LTD](https://specstream.ai/data/institutional-holders/inmode-ltd-m5425m103) | SHS | 120,942 | $1.8 million | No change |
| [Evolus Inc](https://specstream.ai/data/institutional-holders/evolus-inc-30052c107) | COM | 157,985 | $1.1 million | No change |

## Positions exited in Q2 2026

2 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Indivior Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/indivior-pharmaceuticals-inc-45579u109) | COM | 339,532 | $10.3 million |
| [Alkermes PLC](https://specstream.ai/data/institutional-holders/alkermes-plc-g01767105) | SHS | 107,822 | $3.8 million |

## Also on SpecStream

- [Krensavage Asset Management, LLC Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1609251/000160925126000005/0001609251-26-000005-index.htm)
- [Krensavage Asset Management, LLC investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/krensavage-asset-management-llc-168976)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Kosher restaurants in New York, New York](https://specstream.ai/data/businesses/kosher-restaurants/new-york-new-york-united-states)
- [Eye care clinics in New York, New York](https://specstream.ai/data/businesses/eye-care-clinics/new-york-new-york-united-states)
- [Clothing companies in New York, New York](https://specstream.ai/data/businesses/clothing-companies/new-york-new-york-united-states)
- [Alternative medicine clinics in New York, New York](https://specstream.ai/data/businesses/alternative-medicine-clinics/new-york-new-york-united-states)
- [Shipping and delivery companies in New York, New York](https://specstream.ai/data/businesses/shipping-and-delivery-companies/new-york-new-york-united-states)
- [Office supply stores in New York, New York](https://specstream.ai/data/businesses/office-supply-stores/new-york-new-york-united-states)
